GGrantIndex
Sort

34,240 grants matching atherosclerosis

Obesity-related epigenetic changes and type-2 diabetes

$651,436
Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2017 · DK

Reprogramming of mature smooth muscle cells to vascular progenitor cells

$651,434
Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2019 · HL

Endothelial Dysfunction and the RV in the Multi-Ethnic Study of Atherosclerosis

$651,279
Steven M Kawut · Columbia University Health Sciences · R01 · FY2007 · HL

Helicobacter pylori infection and endothelial dysfunction

$651,257
Zhenguo Liu · University Of Missouri-Columbia · R01 · FY2022 · HL

The health status of Caucasian and African American living with kidney donors

$651,196
Sandra J Taler · Mayo Clinic Rochester · U01 · FY2008 · AI

Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

$651,143
Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2023 · HL

Inactivity, sedentary behavior, and the risk for Alzheimer’s disease in middle aged to older adults

$651,124
David Raichlen · University Of Southern California · R01 · FY2025 · AG

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5

$650,936
Thomas H Mosley · University Of Mississippi Med Ctr · U01 · FY2018 · HL

HEG1 in endothelial function and atherosclerosis

$650,926
Hanjoong Jo · Emory University · R01 · FY2024 · HL

Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics

$650,841
Sanjiv J Shah · Northwestern University At Chicago · R01 · FY2019 · HL

Telomeres and Female Fecundity

$650,833
Abraham Aviv · Rbhs-New Jersey Medical School · R01 · FY2017 · HL

Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD

$650,695
Ani Wang Manichaikul · University Of Virginia · R01 · FY2023 · HL

Mediators of Atherosclerosis in South Asians Living in America

$650,642
Alka M Kanaya · University Of California, San Francisco · R01 · FY2018 · HL

Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic

$650,536
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease

$650,536
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

The Relevance of Arterial Stiffness and Vascular Calcium to Blood Pressure and LV Structure and Function.

$650,494
Matthew A Allison · University Of California, San Diego · R01 · FY2021 · HL

Airway Tree Subtyping on Large Cohorts of CT Images for COPD Risk

$650,448
Andrew Francis Laine · Columbia University Health Sciences · R01 · FY2022 · HL

Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis

$650,445
Peter Libby · Brigham And Women'S Hospital · R01 · FY2025 · HL

Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis

$650,445
Peter Libby · Brigham And Women'S Hospital · R01 · FY2023 · HL

Bile acids and insulin sensitivity

$650,344
Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2021 · DK

Air Pollution, Subclinical CVD and Inflammatory Markers in the SEARCH Cohort

$650,293
Robin Puett · Univ Of Maryland, College Park · R01 · FY2011 · ES

HDL composition/function and cardiovascular risk in youths with diabetes

$650,228
Tomas Vaisar · University Of Washington · R01 · FY2021 · HL

Molecular Regulation of Atherosclerosis Regression

$650,162
Edward A Fisher · New York University School Of Medicine · R01 · FY2012 · HL

Molecular Regulation of Atherosclerosis Regression

$650,162
Edward A Fisher · New York University School Of Medicine · R01 · FY2011 · HL

Epidemiology of CHD of Men Aged 40+

$650,148
University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL